C31G oral rinse
Alternative Names: 0.5% C31G oral rinse; 0.5% glyminox; OramedLatest Information Update: 24 Oct 2021
At a glance
- Originator Biosyn
- Class Amines; Antibacterials; Antivirals; Small molecules; Spermicidal contraceptives; Unsaturated fatty acids
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 31 Dec 2006 Discontinued - Phase-I/II for Candidiasis in USA (PO)
- 15 Dec 2004 Biosyn has been acquired by Cellegy Pharmaceuticals
- 12 Oct 2004 Cellegy Pharmaceuticals has entered into a definitive agreement to acquire Biosyn